Blacket R B, Woodhill J M, Leelarthaepin B, Palmer A J
Lancet. 1975 Sep 20;2(7934):517-20. doi: 10.1016/s0140-6736(75)90894-6.
Twenty men with mild to moderate type-IV hypertriglyceridaemia were compared with normal men of the same age in the Busselton population survey. The type-IV men were not heavier but they were 3-2 cm. shorter and relatively hyperuricaemic. When gives a reducing diet, mean weight declined from 76-8 kg. to 68-7 kg. over 4-4 months and was kept steady over the next 10 months at 67-6 kg. Before, immediately after, and in the 10 months after weight reduction serum-triglycerides were 273, 112, and 126 mg. per 100 ml. and serum-cholesterol was 245, 227, and 226 mg. per 100 ml., respectively. On entry the mean daily calorie intake was 3165 and the contribution of the various nutrients were characteristic of the Australian diet. At lower weight, daily caloric intake was 2335. Protein intake was unchanged, but intake of fat and especially carbohydrate declined significantly. The findings support the view that type-IV hyperlipidaemia is the expression of a metabolic defect brought to light by weight-gain after maturity. In susceptible subjects "normal" weight-gain may be sufficient to induce hyperlipidaemia. Since type-IV and type-IIb hypertriglyceridaemias appear to increase the risk of coronary heart-disease, it is concluded that ideally no weight should be gained after reaching maturity. Avoidance of weight-gain should materially reduce the incidence of coronary disease in affluent western communities. Reduction to truly ideal weight gives much more impressive therapeutic results than drug therapy.
在巴瑟尔顿人群调查中,将20名患有轻度至中度IV型高甘油三酯血症的男性与相同年龄的正常男性进行了比较。IV型男性体重并不更重,但身高矮3 - 2厘米,且相对血尿酸过高。给予低热量饮食后,平均体重在4 - 4个月内从76.8千克降至68.7千克,并在接下来的10个月内稳定在67.6千克。在体重减轻前、刚减轻后以及减轻后的10个月,血清甘油三酯分别为每100毫升273毫克、112毫克和126毫克,血清胆固醇分别为每100毫升245毫克、227毫克和226毫克。入组时平均每日热量摄入为3165千卡,各种营养素的贡献具有澳大利亚饮食的特点。体重降低后,每日热量摄入为2335千卡。蛋白质摄入量不变,但脂肪尤其是碳水化合物的摄入量显著下降。这些发现支持了这样一种观点,即IV型高脂血症是成熟后体重增加所揭示的代谢缺陷的表现。在易感人群中,“正常”的体重增加可能足以诱发高脂血症。由于IV型和IIb型高甘油三酯血症似乎会增加冠心病的风险,得出的结论是,理想情况下成熟后不应增加体重。避免体重增加应能大幅降低富裕西方社区冠心病的发病率。将体重降至真正理想水平比药物治疗能带来更显著的治疗效果。